Biofilm dispersal cells of a cystic fibrosis Pseudomonas aeruginosa isolate exhibit variability in functional traits likely to contribute to persistent infection

FEMS Immunology and Medical Microbiology

Volumn 66, Issue 2, 2012, Pages 251-264

  Woo, Jerry K K ^a   Webb, Jeremy S ^a,d   Kirov, Sylvia M ^b   Kjelleberg, Staffan ^a,c   Rice, Scott A ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Adaptation; Biofilm; Phenotypic variation; Pseudomonas aeruginosa

Indexed keywords

CARBON; ELASTASE; PROTEINASE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOFILM; CYSTIC FIBROSIS; ENZYME ACTIVITY; MICROBIAL POPULATION DYNAMICS; MORPHOTYPE; MUTATION RATE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; QUORUM SENSING;

ACYL-BUTYROLACTONES; BIOFILMS; CARBOHYDRATE METABOLISM; CYSTIC FIBROSIS; HUMANS; MUTATION RATE; PANCREATIC ELASTASE; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84867692716     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2012.01006.x     Document Type: Article

References (60)

1. Allegrucci M, Hu FZ, Shen K, Hayes J, Erhrlich GD, Post JC & Sauer K (2006) Phenotypic characterization of Streptococcus pneumoniae biofilm development. J Bacteriol 188: 2325-2335.
2. Barraud N, Schleheck D, Klebensberger J, Webb JS, Hassett DJ, Rice SA & Kjelleberg S (2009) Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J Bacteriol 191: 7333-7342.
3. Bjarnsholt T, Jensen P, Burmolle M et al. (2005) Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 151: 373-383.
4. Bjarnsholt T, Jensen PO, Jakobsen TH et al. (2010) Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients. PLoS ONE 12: e10115.
5. Boucher RC (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 23: 146-158.
6. Boulette ML, Baynham PJ, Jorth PA, Kukavica-Ibrulj I, Longoria A, Barrera K, Levesque RC & Whiteley M (2009) Characterization of alanine catabolism in Pseudomonas aeruginosa and its importance for proliferation in vivo. J Bacteriol 191: 6329-6334.
7. Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, Rejman J, Di Serio C, Doring G & Tummler B (2009) Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med 180: 138-145.
8. Cano DA, Pucciarelli MG, Martinez-Moya M, Casadesus J & Garcia-del Portillo F (2003) Selection of small colony-variants of Salmonella enterica serovar typhimurium in nonphagocytic eucaryotic cells. Infect Immun 71: 3690-3698.
9. Ceri H, Olson ME, Stremick CA, Read RR, Morck D & Buret A (1999) The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37: 1771-1776.
10. Conibear TCR, Collins SL & Webb JS (2009) Role of mutation in Pseudomonas aeruginosa biofilm development. PLoS ONE 4: e6289.
11. D'Argenio DA, Wu M, Hoffman LR et al. (2007) Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 64: 512-533.
12. Déziel E, Comeau Y & Villemur R (2001) Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming and twitching motilities. J Bacteriol 183: 1195-1204.
13. Drenkard E & Ausubel FM (2002) Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416: 740-743.
14. Elsheikh LE, Kronevi T, Wretlind B, Abaas S & Iglewski BH (1987) Assessment of elastase as a Pseudomonas aeruginosa virulence factor in experimental lung infection in mink. Vet Microbiol 13: 281-289.
15. Feng G, Tsui HC & Winkler ME (1996) Depletion of the cellular amounts of the MutS and MutH methyl-directed mismatch repair proteins in stationary-phase Escherichia coli K-12 cells. J Bacteriol 178: 2388-2396.
16. Fuqua C & Winans SC (1996) Conserved cis-acting promoter elements are required for density-dependent transcription of Agrobacterium tumefaciens conjugal transfer genes. J Bacteriol 178: 435-440.
17. Garcia-Castillo M, Del Campo R, Baquero F, Morosini MI, Turrientes MC, Zamora J & Cantón R (2011) Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis. Clin Microbiol Infect 17: 704-711.
18. Govan JRW & Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60: 539-574.
19. Grimwood K, Semple RA, Rabin HR, Sokol PA & Woods DE (1993) Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis. Pediatr Pulmonol 15: 135-139.
20. Hassett DJ, Sutton MD, Schurr MJ, Herr AB, Caldwell CC & Matu JO (2009) Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol 17: 130-138.
21. Häußler S (2004) Biofilm formation by the small colony variant phenotype of Pseudomonas aeruginosa. Environ Microbiol 6: 546-551.
22. Häußler S, Ziegler I, Löttel A, von Götz F, Rohde M, Wehmhöhner D, Saravanamuthu S, Tümmler B & Steinmetz I (2003) Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J Med Microbiol 52: 295-301.
23. Heurlier K, Denervaud V & Haas D (2006) Impact of quorum sensing on fitness of Pseudomonas aeruginosa. Int J Med Microbiol 296: 93-102.
24. Hoboth C, Hoffman LR, Eichner A, Henke C, Schmoldt S, Imhof A, Heesemann J & Hogardt M (2009) Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis 200: 118-130.
25. Hoffman LR, Kulasekara HD, Emerson J, Houston LS, Burns JL, Ramsey BW & Miller SI (2009) Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J Cyst Fibros 8: 66-70.
26. Hogardt M & Heesemann J (2010) Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int J Med Microbiol 300: 557-562.
27. Holloway BW (1955) Genetic recombinant in Pseudomonas aeruginosa. J Gen Microbiol 13: 572-581.
28. Jaffar-Bandjee MC, Lazdunski A, Bally M, Carrere J, Chazalette JP & Galabert C (1995) Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa. J Clin Microbiol 33: 924-929.
29. Justice SS, Hung C, Therlot JA, Fletcher DA, Anderson GG, Footer MJ & Hultgren SJ (2004) Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. P Natl Acad Sci USA 101: 1333-1338.
30. Kirov SM, Webb JS & Kjelleberg S (2005) Clinical significance of seeding dispersal in biofilms. Microbiology 151: 3452-3453.
31. Kirov SM, Webb JS, O'May CY, Reid DW, Woo J, Rice SA & Kjelleberg S (2007) Biofilm differentiation and dispersal in mucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Microbiology 153: 3264-3274.
32. Koh KS, Lam KW, Alhede M, Queck SY, Labbate M, Kjelleberg S & Rice SA (2007) Phenotypic diversification and adaptation of Serratia marcescens MG1 biofilm-derived morphotypes. J Bacteriol 189: 119-130.
33. Mai-Prochnow A, Evans F, Dalisay-Saludes D, Stelzer S, Egan S, James S, Webb JS & Kjelleberg S (2004) Biofilm development and cell death in the marine bacterium Pseudoalteromonas tunicata. Appl Environ Microbiol 70: 3232-3238.
34. Malone JG, Jaeger T, Spangler C, Ritz D, Spang A, Arrieymerlou C, Kaever V, Landmann R & Jenal U (2010) YfiBNR mediates cyclic di-GMP dependent small colony variant formation and persistence in Pseudomonas aeruginosa. PLoS Pathog 6: e1000804.
35. Martinez-Granero F, Capdevila S, Sanchez-Contreras M, Martin M & Rivilla R (2005) Two site-specific recombinases are implicated in phenotypic variation and competitive rhizosphere colonization in Pseudomonas fluorescens. Microbiology 151: 975-983.
36. McClean KH, Winson MK, Fish L et al. (1997) Quorum sensing and Chromobacterium violaceum: exploitation of violacein production and inhibition for the detection of N-acylhomoserine lactones. Microbiology 143: 3703-3711.
37. Moller S, Pedersen AR, Poulsen LK, Arvin E & Molin S (1996) Activity and three-dimensional distribution of toluene-degrading Pseudomonas putida in a multispecies biofilm assessed by quantitative in situ hybridization and scanning confocal laser microscopy. Appl Environ Microbiol 62: 4632-4640.
38. Oliver A, Baquero F & Blazquez J (2002) The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol Microbiol 43: 1641-1650.
39. O'May CY, Reid DW & Kirov SM (2006) Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. FEMS Immunol Med Microbiol 48: 373-380.
40. O'Toole GA & Kolter R (1998) Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 28: 449-461.
41. Palmer KL, Mashburn LM, Singh PK & Whiteley M (2005) Cystic fibrosis sputum growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 187: 5267-5277.
42. Palmer KL, Aye LM & Whiteley M (2007) Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 189: 8079-8087.
43. Pratt LA & Kolter R (1998) Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol 30: 295-304.
44. Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M & Peters G (2006) Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4: 295-305.
45. Rau MH, Handsen SK, Johansen HK, Thomsen LE, Workman CT, Nielsen KF, Jelsbak L, Hoiby N, Yang L & Molin S (2010) Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. Environ Microbiol 12: 1643-1658.
46. Rice SA, Tan CH, Mikkelsen PJ, Kung V, Woo J, Tay M, Hauser A, McDougald D, Webb JS & Kjelleberg S (2009) The biofilm life cycle and virulence of Pseudomonas aeruginosa are dependent on a filamentous prophage. ISME J 3: 271-282.
47. Rowntree RK & Harris A (2003) The phenotypic consequences of CFTR mutations. Ann Hum Genet 67: 471-485.
48. Sauer K, Camper AK, Ehrlich GD, Costerton JW & Davies DG (2002) Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 184: 1140-1154.
49. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ & Greenberg EP (2000) Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407: 762-764.
50. Smith EE, Buckley DG, Wu Z et al. (2006a) Genetic adaptations by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. P Natl Acad Sci USA 103: 8487-8492.
51. Smith L, Rose B, Tingpej P et al. (2006b) Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis. J Med Microbiol 55: 1641-1644.
52. Sriramulu DD, Lünsdorf H, Lam JS & Römling U (2005) Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J Med Microbiol 54: 667-676.
53. Starkey M, Hickman JH, Ma L et al. (2009) Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung. J Bacteriol 191: 3492-3503.
54. Tingpej P, Smith L, Rose B et al. (2007) Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. J Clin Microbiol 45: 1697-1704.
55. Webb JS, Thompson LS, James S, Charlton T, Tolker-Nielsen T, Koch B, Givskov M & Kjelleberg S (2003) Cell death in Pseudomonas aeruginosa biofilm formation. J Bacteriol 185: 4585-4592.
56. Webb JS, Lau M & Kjelleberg S (2004) Bacteriophage and phenotypic variation in Pseudomonas aeruginosa biofilm formation. J Bacteriol 186: 8066-8073.
57. Wilcox MDP, Zhu H, Conibear TCR, Hume EBH, Givskov M, Kjelleberg S & Rice SA (2008) Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis. Microbiology 164: 2184-2194.
58. Williams BJ, Dehnbostel J & Blackwell TS (2010) Pseudomonas aeruginosa: host defence in lung diseases. Respirology 15: 1037-1056.
59. Workentine ML, Harrison JJ, Weljie AM, Tran VA, Stenroos PU, Tremaroli V, Vogel HJ, Ceri H & Turner RJ (2010) Phenotypic and metabolic profiling of colony morphology variants evolved from Pseudomonas fluorescens biofilms. Environ Microbiol 12: 1565-1577.
60. Worlitzsch D, Tarran R, Ulrich M et al. (2002) Effect of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis. J Clin Invest 3: 317-325.